Alejandro Mora, Ferrer’s country manager for Central America & Caribbean, discusses the complexity of the region’s healthcare systems, the company’s strategy to compete against local players, and the importance for multinational companies of going beyond the pill in the region, making efforts to be sustainable and help the environment.
The main obstacle for any research-based pharmaceutical company in this region is the complex regulatory environment
Genald Senior, general manager for Leterago, the leading pharma distributor in the Dominican Republic, discusses how the company has managed to control over a fifth of the market, the country’s…
Alejandro Paolini, Siemens Healthineers’ managing director for Mexico, Central America and Caribbean, dives into the medical technology industry’s business model transformation, switching from selling products to services with a risk-sharing…
Medtronic’s VP for North Latin America, Héctor Orellana, outlines the largest company’s new vision for that region, their efforts and challenges to continue gaining market access, and explains why the…
The rise of the Dominican Republic as a regional medtech manufacturing hub might have come as a surprise to many, but not to the insiders and executives of the Central…
See our Cookie Privacy Policy Here